h1

h2

h3

h4

h5
h6
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png

Efficacy of Bosutinib in Imatinib-Resistant vs Dasatinib/Nilotinib-Resistant Chronic Phase Chronic Myeloid Leukemia : Results from the Phase 4 BYOND Study = CML-277: Efficacy of Bosutinib in Imatinib-Resistant vs Dasatinib/Nilotinib-Resistant Chronic Phase Chronic Myeloid Leukemia : Results from the Phase 4 BYOND Study

; ; ; ; ; ; ; ; ; ; ;

In
Proceedings of the Society of Hematologic Oncology 2020 Annual Meeting

In
Clinical lymphoma, myeloma & leukemia 20(Supplement 1), Seiten/Artikel-Nr.:S240-S240

Konferenz/Event:Society of Hematologic Oncology 2020 Annual Meeting , online , SOHO 2020 , 2020-09-09 - 2020-09-12

ImpressumAmsterdam [u.a.] : Elsevier

ISSN2152-2650

Online
DOI: 10.1016/S2152-2650(20)30826-0


Einrichtungen

  1. Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie) (531040-2)



Dokumenttyp
Abstract/Journal Article/Contribution to a conference proceedings

Format
online, print

Sprache
English

Externe Identnummern
OpenAlex: W2985522202

Interne Identnummern
RWTH-CONV-243384
Datensatz-ID: 812423

Beteiligte Länder
France, Germany, Italy, Spain, USA

Lizenzstatus der Zeitschrift

 GO


Medline ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

QR Code for this record

The record appears in these collections:
Document types > Events > Contributions to a conference proceedings
Document types > Articles > Journal Articles
Document types > Presentations > Abstracts
Faculty of Medicine (Fac.10)
Public records
531040\-2
Import Publication
Publications database

 Record created 2021-02-12, last modified 2026-09-10



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)